MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.
MALT1抑制剂对原发性和伊布替尼耐药的慢性淋巴细胞白血病均有效
期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-17-2485
Saba Nakhle S, Wong Deanna H, Tanios Georges, Iyer Jessica R, Lobelle-Rich Patricia, Dadashian Eman L, Liu Delong, Fontan Lorena, Flemington Erik K, Nichols Cydney M, Underbayev Chingiz, Safah Hana, Melnick Ari, Wiestner Adrian, Herman Sarah E M
